HAOHAI BIOLOGICAL TECHNOLOGY
Haohai Biological Technology（0682 6.HK） is a leading company in the PRC focusing on the Research and development, manufacturing and sales of biomedical materials and we strategically target the fast-growing therapeutic areas including ophthalmology, medical aesthetics and would care, orthopedics and anti-adhesion and hemostasis in China
HAOHAI BIOLOGICAL TECHNOLOGY
Industry:
Health Care Manufacturing
Status:
Active
Contact:
+86 21 52293555
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Euro DigiCert SSL Pound Sterling Japanese Yen Java EE Encryption Everywhere Nginx 1.16
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-02 | Nanpeng Optics | Nanpeng Optics acquired by Haohai Biological Technology | 70 M CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-21 | ArcScan | Haohai Biological Technology investment in Series B - ArcScan | 11.15 M USD |
| 2021-03-09 | Eirion Therapeutics | Haohai Biological Technology investment in Series A - Eirion Therapeutics | 40 M USD |
More informations about "Haohai Biological Technology"
Haohai Biological Technology - About Us - 3healthcare.com
Shanghai Haohai Biological Technology Co., Ltd. (together with its subsidiaries hereinafter referred to as "Haohai ") is a technology innovative enterprise that utilizes biomedical material …See details»
Haohai Biological Technology - Crunchbase
Haohai Biological Technology（0682 6.HK） is a leading company. Haohai Biological Technology（0682 6.HK） is a leading company in the PRC focusing on the Research and …See details»
Haohai Biological Technology - Investor Relations
Haohai Biological Technology is a leading company in the PRC focusing on the Research and development, manufacturing and sales of absorbable biomedical materials and we …See details»
Haohai Biological Technology - LinkedIn
Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas ...See details»
688366 | SHANGHAI STOCK EXCHANGE - s se
Shanghai Haohai Biological Technology Co.,Ltd 688366. Brief Introduction. Haohai is a high-tech biomedical enterprise focus on the research and development, manufacturing and sales of …See details»
Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
See the company profile for Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) including business summary, industry/sector information, number of employees, business summary, …See details»
ArcScan Announces New Leadership, Firm Commitment to …
Jul 22, 2024 DENVER, COLORADO, July 19 — Today ArcScan, Inc. (ArcScan) announced the appointment of J. Erik Giphart, Ph.D., to succeed Andy Levien as its new CEO. Mr. Giphart is …See details»
Haohai Biological Technology - Investments, Portfolio & Company …
Haohai Biological Technology has acquired Nanpeng Optics on Dec 2, 2021. They acquired Nanpeng Optics for CN¥70M . Which types of acquisition does this organization make most …See details»
Haohai Biological Technology Company Profile - Craft
Haohai Biological Technology Summary. Company Summary. Overview. Haohai Biological Technology is a company that designs and manufactures biomedical materials. It provides …See details»
Founder of biotech company makes the cut - 上海市政府
Oct 18, 2021 In a field he had never set foot in, Wu worked hard, figuring out his way, which also laid a solid foundation for later entrepreneurs. In 2007, Wu and his team merged and acquired …See details»
6826.HK - | Stock Price & Latest News | Reuters
3 days ago Shanghai Haohai Biological Technology Co Ltd 6826.HK. Official Data Partner. Latest Trade. trading lower 27.35 HKD. Change-0.35 % Change-1.26% Negative As of Dec 5, …See details»
Haohai Biological Technology - Milestone
Haohai Biological Technology is a leading company in the PRC focusing on the Research and development, manufacturing and sales of absorbable biomedical materials and we …See details»
With UBS as Bookrunner, Haohai Biotech Goes Public on Star Market
Oct 21, 2019 Hong Kong-listed company Haohai Biological Technology (昊海生科, 6826:HK, 688366:SH) has confirmed its intention to launch a second public offering, this time on the …See details»
Shanghai Haohai Biological Technology Co., Ltd. ESG Risk Rating
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. ... can be used to identify areas …See details»
Shanghai Haohai Biological Technology sees highest filings and …
Shanghai Haohai Biological Technology saw the highest growth of 299% in patent filings and 399% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment …
WOBURN, Mass., March 9, 2021 / PRNewswire / -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»
Founder of biological technology company makes the cut
Oct 15, 2021 In 2007, Wu and his team merged and acquired three old stated-owned companies which used to develop, produce and sell medical sodium hyaluronate, forming the foundation …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment …
Mar 9, 2021 Haohai Biological Technology is a leading company in China focusing on the research and development, manufacturing and sales of biomedical materials. Haohai …See details»
Eirion Therapeutics Closes $40M Series A Investment and …
Mar 10, 2021 Eirion Therapeutics, Inc. closed a $40 million Series A investment and licensing deal with Shanghai Haohai Biological Technology Ltd. The deal will result in a $32 million …See details»